当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析

康泰医学

(300869)

  

流通市值:39.37亿  总市值:62.88亿
流通股本:2.52亿   总股本:4.02亿

康泰医学(300869)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年半年度实现净利润0.08亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年半年度最新股东权益193250.47万元,未分配利润97847.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年半年度最新总资产283482.66万元,负债90232.19万元。

利润表
报告期2024-06-302024-03-312023-12-312023-09-30
营业总收入211,789,804.5299,175,164.46746,902,140.39617,227,119.11
营业总成本212,974,691.76102,176,199.13568,889,907.42429,154,337.97
营业利润7,906,278.512,807,644.45186,734,053.22220,339,813.86
利润总额8,504,332.323,119,219.51186,125,825.61220,165,922.14
净利润8,167,120.794,351,935.11165,765,985.8195,117,554.43
其他综合收益78,993.98-135,263.53761,799.61,332,195.88
综合收益总额8,246,114.774,216,671.58166,527,785.4196,449,750.31
资产负债表
报告期2024-06-302024-03-312023-12-312023-09-30
流动资产合计1,869,207,101.022,150,686,350.482,482,164,235.522,636,067,417.34
非流动资产合计965,619,493.36947,578,191.73729,782,416.65830,164,396.4
资产总计2,834,826,594.383,098,264,542.213,211,946,652.173,466,231,813.74
流动负债合计179,457,714.33333,596,329.15459,938,077.63692,252,107.01
非流动负债合计722,864,223.27715,652,570707,211,885.26699,261,564.49
负债合计902,321,937.61,049,248,899.151,167,149,962.891,391,513,671.5
归属于母公司股东权益合计1,932,504,656.782,049,015,643.062,044,796,689.282,074,718,142.24
股东权益合计1,932,504,656.782,049,015,643.062,044,796,689.282,074,718,142.24
负债和股东权益合计2,834,826,594.383,098,264,542.213,211,946,652.173,466,231,813.74
现金流量表
报告期2024-06-302024-03-312023-12-312023-09-30
经营活动现金流入小计237,030,254.24110,319,968.53989,163,696.49838,260,774.94
经营活动现金流出小计223,165,786.6110,866,407.97808,148,976.06660,538,460.96
经营活动产生的现金流量净额13,864,467.64-546,439.44181,014,720.43177,722,313.98
投资活动现金流入小计3,023,454,927.61,254,098,774.06167,777,527.28121,754,759.57
投资活动现金流出小计2,617,539,347.99973,982,712.86890,735,599.29838,773,729.34
投资活动产生的现金流量净额405,915,579.61280,116,061.2-722,958,072.01-717,018,969.77
筹资活动现金流入小计90,000,000143,160,301.371,077,878,400752,371,600.44
筹资活动现金流出小计475,884,145.94142,278,214.921,461,317,612.451,244,315,368.57
筹资活动产生的现金流量净额-385,884,145.94882,086.45-383,439,212.45-491,943,768.13
汇率变动对现金及现金等价物的影响2,899,452.821,898,965.285,282,712.76,881,813.01
现金及现金等价物净增加额36,795,354.13282,350,673.49-920,099,851.33-1,024,358,610.91
期末现金及现金等价物余额504,018,600.86749,573,920.22467,223,246.73362,964,487.15
TOP↑